Since the clinical manifestations of each form of CAH are unique and depend to a large extent on the underlying enzyme defects, their precursor retention and defective products, the therapeutic goal of CAH is to replenish insufficient adrenal hormones and suppress excess of precursors. Treatment of all forms of CAH may include any of: # Supplying enough glucocorticoid to reduce hyperplasia and overproduction of androgens or mineralocorticoids # Providing replacement mineralocorticoid and extra salt if the person is deficient # Providing replacement testosterone or estrogens at puberty if the person is deficient # Additional treatments to optimize growth by delaying puberty or delaying bone maturation If CAH is<unk> d by the deficiency of the 21-hydroxylase enzyme, then treatment aims to normalize levels of main substrate of the enzyme - 17α-hydroxyprogesterone.
medical cause of Primary aldosteronism
complications of Primary aldosteronism
symptom of Primary aldosteronism
symptom of Pheochromocytoma
causes of Primary aldosteronism
complications of Diabetes insipidus
complications of Acromegaly
symptom of Syndrome of inappropriate antidiuretic hormone secretion